Last reviewed · How we verify
NCT04200482
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors
Phase 2 trial testing One Diet and Physical Activity Session in Anatomic Stage 0 Breast Cancer AJCC v8 in 90 participants. Completed in 28 October 2021.
24 August 2021
Quick facts
| Lead sponsor | Fred Hutchinson Cancer Center |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 90 |
| Start date | 21 February 2020 |
| Primary completion | 24 August 2021 |
| Estimated completion | 28 October 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- One Diet and Physical Activity Session
- Electronic (e) Health (eHealth) Communication Intervention
- Twelve Diet and Physical Activity Group Sessions
- Questionnaire Administration
- Quality-of-Life Assessment
Conditions studied
- Anatomic Stage 0 Breast Cancer AJCC v8 — all drugs for Anatomic Stage 0 Breast Cancer AJCC v8 →
- Anatomic Stage I Breast Cancer AJCC v8 — all drugs for Anatomic Stage I Breast Cancer AJCC v8 →
- Anatomic Stage IA Breast Cancer AJCC v8 — all drugs for Anatomic Stage IA Breast Cancer AJCC v8 →
- Anatomic Stage IB Breast Cancer AJCC v8 — all drugs for Anatomic Stage IB Breast Cancer AJCC v8 →
Sponsor
Fred Hutchinson Cancer Center — full company profile →
Who can join
18 and older, female only, with Anatomic Stage 0 Breast Cancer AJCC v8 or Anatomic Stage I Breast Cancer AJCC v8. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this phase II trial is to identify the most effective dose level (number of classes) of a diet and physical activity lifestyle program based on how well it improves diet and physical activity in stage 0-III breast cancer survivors. Study results may provide researchers with information on how to best implement diet and physical activity recommendations among breast cancer survivors.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Characteristics of Users of the Cook for Your Life Website, an Online Nutrition Resource for Persons Affected by Cancer: Descriptive Study.
Rillamas-Sun E, Schattenkerk L, Cobos S, Ueland K, et al · · 2022 · cited 4× · PMID 35788100 · DOI 10.2196/37212 -
Cook and Move for Your Life, an eHealth intervention for women with breast cancer.
Greenlee H, Rillamas-Sun E, Yung RL, Cobos S, et al · · 2024 · cited 1× · PMID 39054321 · DOI 10.1038/s41523-024-00662-2 -
A Digital Health Intervention to Improve Nutrition and Physical Activity in Breast Cancer Survivors: Rationale and Design of the Cook and Move for Your Life Pilot Randomized Controlled Trial
Ueland K, Sanchez SC, Rillamas-Sun E, Shen H, et al · · 2022 · DOI 10.2139/ssrn.4179191
Verify or expand the search:
- PubMed search for NCT04200482
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anatomic Stage 0 Breast Cancer AJCC v8
Currently open trials in the same condition.
- NCT07443943 — A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive · Phase 2 · recruiting
- NCT07044310 — 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss · Phase 2 · recruiting
- NCT06401889 — Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy · recruiting
- NCT06297265 — Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery · NA · recruiting
- NCT06153836 — Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Spari · Phase 2 · recruiting
Other Fred Hutchinson Cancer Center trials
Trials by the same sponsor.
- NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati · Phase 2 · not yet recruiting
- NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers · NA · not yet recruiting
- NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
- NCT07194980 — Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small L · Phase 2 · not yet recruiting
- NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04200482 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fred Hutchinson Cancer Center
- Last refreshed: 4 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04200482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing